pvla: the income statement

MyFinsight

PALVELLA THERAPEUTICS, INC. (PVLA)

For the quarter ending 2025-06-30, PVLA made $1,251K in revenue. -$9,579K in net income. Net profit margin of -765.71%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Foreign currency translation loss	-108
Less cumulative series d preferred dividends	-
Income tax benefit (expense)	-
Fair value adjustments on derivative liabilities - royalty agreement	-118
Other income, net	561
Research and development	5,118
General and administrative	4,132
Total operating expenses	9,250
Operating loss	-9,250
Interest income (expense), net	690
Interest expense - convertible notes payable	-
Interest expense - royalty agreement	-1,354
Loss before income taxes	-9,471
Net loss	-9,471
Loss attributable to common stockholders	-9,471
Comprehensive loss	-9,579

Basic (in shares)	11,052,741
Diluted (in shares)	11,052,741
Us-gaap_earningspersharebasic	-0.86
Us-gaap_earningspersharediluted	-0.86

Unit: Thousand (K) dollars (except for numbers of shares and EPS)